Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/185.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same
Description: Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.

Sub-classes under this class:

Class Number Class Name Patents
424/190.1 Disclosed amino acid sequence derived from bacterium (e.g., mycoplasma, anaplasma, etc.) 982
424/191.1 Disclosed amino acid sequence derived from parasitic organism (e.g., dirofilaria, eimeria, trichinella, etc.) 255
424/186.1 Disclosed amino acid sequence derived from virus 602

Patents under this class:

Patent Number Title Of Patent Date Issued
8710004 Stable liquid VEGF antagonist formulations Apr. 29, 2014
8709446 HYR1 as a target for active and passive immunization against Candida Apr. 29, 2014
8709435 Hypallergenic mosaic antigens and methods of making same Apr. 29, 2014
8709434 Compositions for inhibiting NADPH oxidase activity Apr. 29, 2014
8703908 Expression and export of angiogenesis inhibitors as immunofusins Apr. 22, 2014
8703705 Modified factor VIII peptides Apr. 22, 2014
8703702 Therapeutically active .alpha.-MSH analogues Apr. 22, 2014
8703432 Recombinant Treponema spp. proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same Apr. 22, 2014
8703151 Tuberculosis vaccines comprising antigens expressed during the latent infection phase Apr. 22, 2014
8703148 Immunogenic composition Apr. 22, 2014
8703147 Methods and compositions for treating and preventing malaria (2) Apr. 22, 2014
8703144 Allergen peptide fragments and use thereof for treatment of dust mite allergies Apr. 22, 2014
8691945 Antimicrobial peptides Apr. 8, 2014
8691237 Brucella abortus proteins and methods of use thereof Apr. 8, 2014
8691236 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis Apr. 8, 2014
8685404 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Apr. 1, 2014
8685403 Insulin-like growth factor signaling and integrin Apr. 1, 2014
8673319 Chimpanzee adenovirus vaccine carriers Mar. 18, 2014
8673293 Use of modified cells for the treatment of multiple sclerosis Mar. 18, 2014
8669355 Vaccine Mar. 11, 2014
8663651 T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation Mar. 4, 2014
8663647 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides Mar. 4, 2014
8663646 P53 peptide vaccine Mar. 4, 2014
8663645 Use of native peptides and their optimized derivatives for vaccination Mar. 4, 2014
8658766 Soluble hybrid Fc.gamma. receptors and related methods Feb. 25, 2014
8658180 Vaccines against influenza virus Feb. 25, 2014
8658177 Promiscuous HER-2/Neu CD4 T cell epitopes Feb. 25, 2014
8658176 Lipidated tumor-associated antigens and immunotherapeutic compositions Feb. 25, 2014
8652488 Insulin B chain autoantigen composition Feb. 18, 2014
8652485 Peptide for vaccine Feb. 18, 2014
8652484 Delivery system for cytotoxic drugs by bispecific antibody pretargeting Feb. 18, 2014
8647818 Molecular scaffolds for HIV-1 immunogens Feb. 11, 2014
8647634 Recombinant avian infectious coryza vaccine and process for preparing same Feb. 11, 2014
8647632 Proteins Feb. 11, 2014
8647631 Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines Feb. 11, 2014
8647630 Mite allergen Feb. 11, 2014
8647629 Powerful MHC-class II peptides derived from survivin Feb. 11, 2014
8647628 Peptide epitopes of apolipoprotein B Feb. 11, 2014
8642044 Prevention and treatment of amyloidogenic disease Feb. 4, 2014
8642043 Peptide epitopes of apolipoprotein B Feb. 4, 2014
8637234 Molecular scaffolds for HIV-1 epitopes Jan. 28, 2014
8637053 Chlamydia antigens Jan. 28, 2014
8637041 Secreted Campylobacter flaggella coregulated proteins as immunogens Jan. 28, 2014
8637040 Genus-wide chlamydial peptide vaccine antigens Jan. 28, 2014
8637039 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof Jan. 28, 2014
8637028 Adjuvant incorporation in immunonanotherapeutics Jan. 28, 2014
8637013 Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis Jan. 28, 2014
8632781 Immunogenic compounds comprising peptides of IL1.beta. Jan. 21, 2014
8632780 Human complement C3 derivates with cobra venom factor-like function Jan. 21, 2014
8628781 Prevention and treatment of cast nephropathy Jan. 14, 2014

  Recently Added Patents
Assisting apparatus, method, and program for checking crosstalk noise between hierarchized modules in a semiconductor circuit
Image forming apparatus and control method therefor
Shield for vacuum circuit breaker
Anti-slip strip for vehicle running boards
Method and apparatus to select a profile of a digital communication line
Pull through coronary sinus pacing lead
Motion compensated overlay
  Randomly Featured Patents
Extruded rail for linear motor
Liquid crystal display device to control viewing angle
Pitch degradation with wood colonizing bacteria
Derivatives of (AZA)naphthalenesultam, their preparation and compositions containing them
Ornamental stone
Safety syringe with self-sealing needle retraction and retracted member lock
Lid retainer mechanism for automatic washer
Ball valve to relieve cavity pressure
Bicycle training aid with dynamically deployable balancing features